IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,851,000 | -5.6% | 169,163 | 0.0% | 0.02% | +25.0% |
| Q4 2015 | $1,961,000 | +11.2% | 169,163 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $1,763,000 | -13.6% | 169,163 | 0.0% | 0.02% | -11.1% |
| Q2 2015 | $2,040,000 | -24.6% | 169,163 | 0.0% | 0.02% | -21.7% |
| Q1 2015 | $2,707,000 | -49.0% | 169,163 | -51.1% | 0.02% | -57.4% |
| Q4 2014 | $5,303,000 | +18.2% | 346,160 | 0.0% | 0.05% | -3.6% |
| Q3 2014 | $4,485,000 | -34.4% | 346,160 | -22.4% | 0.06% | -33.3% |
| Q2 2014 | $6,840,000 | +24.4% | 446,160 | 0.0% | 0.08% | +20.0% |
| Q1 2014 | $5,497,000 | -13.3% | 446,160 | -18.3% | 0.07% | -21.3% |
| Q4 2013 | $6,341,000 | +16.1% | 546,160 | +18.4% | 0.09% | +14.1% |
| Q3 2013 | $5,460,000 | -40.4% | 461,160 | -50.0% | 0.08% | -56.9% |
| Q2 2013 | $9,157,000 | – | 922,160 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |